Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins.

Learn about applications
View all Applications
Resources Investors Careers News About Store Community Contact Support

Cancer Translational Research Symposium

Date: Tuesday 7th September
Time: 15:00 - 17:30 (UK time)
Location: online

This Cancer Translational Research Symposium will showcase emerging and innovative use of the robust and reliable nanopore technology in the context of cancer-related biomarker identification and validation.

There will be an opportunity to put your questions to each of our speakers following their talks.

There is no delegate fee for this event. Please register below to attend this event, your place at this event will be confirmed via email from Completion of this form does not constitute confirmation. 

15:00 - 17:3- hrs (UK time) Agenda
15:00 - 15:05 hrs Welcome address

Gordon Sanghera
Oxford Nanopore Technologies Ltd

15:05 - 15:20 hrs Introduction

Emma Stanton
Oxford Nanopore Technologies Ltd

15:20 - 15:45 hrs Cancer WGS on the PromethION

Greg Elgar
Genomics England

15:45 - 16:10 hrs Rapid genomic profiling of hematologic malignancies: an update

Anna Dolnik
Campus Virchow-Klinikum

16:10 - 16:35 hrs Bringing nanopore sequencing to the operating room

Franz-Josef Müller & Helene Kretzmer
Max-Planck-Institute for Molecular Genetics/Christian-Albrechts-University

16:35 - 17:00 hrs Cloud computing for clinical nanopore fusion detection

Cecilia Yeung & Olga Sala-Torra
Fred Hutchinson Cancer Research Center, Clinical Research Division

17:00 - 17:05 hrs Q&A with Emma Stanton

Olivier Lucas
Oxford Nanopore Technologies Ltd

17:05 - 17:30 hrs Online networking

All delegates invited

View speakers